Loxapine Capsule
Product Images NDC 64850-890

5 FDA label images from Elite Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 64850-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Elite Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Loxapine Base Structural Formula (Loxapine 01)

Loxapine Base Structural Formula (Loxapine 01)
Chemical structure diagram of Loxapine base, depicting the molecular framework including rings and functional groups characteristic of Loxapine.*
FDA Label Image

Loxapine Succinate 5mg (Loxapine 02)

Loxapine Succinate 5mg (Loxapine 02)
Label for Loxapine Capsules, USP 5 mg by Elite Laboratories, Inc., containing 100 capsules. Each capsule contains Loxapine Succinate equivalent to 5 mg Loxapine. The label includes storage instructions (20° to 25°C), child-resistant closure requirement, an NDC number (64850-890-01), and a barcode. It advises keeping medication out of the reach of children and refers to the insert for full prescribing information.*
FDA Label Image

Loxapine Succinate 10mg (Loxapine 03)

Loxapine Succinate 10mg (Loxapine 03)
Loxapine Capsules, USP 10 mg oral capsules, in a 100-count container. The label includes the NDC 64850-891-01 and states each capsule contains Loxapine Succinate equivalent to 10 mg Loxapine. Manufactured by Elite Laboratories, Inc., Northvale, NJ. Storage instructions specify 20° to 25°C (68° to 77°F). The label advises dispensing in a child-resistant closure container and includes a barcode.*
FDA Label Image

Loxapine Succinate 25mg (Loxapine 04)

Loxapine Succinate 25mg (Loxapine 04)
Label for Loxapine Capsules, USP 25 mg oral capsules. The label indicates each capsule contains Loxapine Succinate equivalent to 25 mg Loxapine. Packaging is for 100 capsules by Elite Laboratories, Inc., Northvale, NJ. The label includes storage instructions, dispensing requirements, and a barcode.*
FDA Label Image

Loxapine Succinate 50mg (Loxapine 05)

Loxapine Succinate 50mg (Loxapine 05)
Loxapine Capsules, USP 50 mg oral capsules label from Elite Laboratories, Inc., showing a 100-capsule container. The label states each capsule contains Loxapine Succinate equivalent to 50 mg Loxapine. Storage instructions indicate 20 to 25°C (68 to 77°F), and dispensing in a child-resistant closure container per USP. The label includes a barcode and manufacturer address in Northvale, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.